These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 10632350

  • 1. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong.
    Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
    [Abstract] [Full Text] [Related]

  • 2. [Effect of overexpression of P53 protein in colorectal carcinoma on short-term prognosis].
    Domínguez Iglesias F, Riera Velasco JR, Junco Petrement P, Tojo Ramallo P, Díaz-Faes Cervero M.
    Rev Esp Enferm Dig; 1994 Nov; 86(5):796-802. PubMed ID: 7848689
    [Abstract] [Full Text] [Related]

  • 3. [P53 protein in adenocarcinoma of the large intestine].
    Paluszkiewicz P, Pawłowska-Wakowicz B, Cybulski M, Berbeć H.
    Wiad Lek; 1997 Nov; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
    [Abstract] [Full Text] [Related]

  • 4. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
    Fante R, Di Gregorio C, Losi L, Roncucci L, Ponz de Leon M.
    Ital J Gastroenterol; 1996 May; 28(4):205-10. PubMed ID: 8842835
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
    Zavrides H, Zizi-Sermpetzoglou A, Elemenoglou I, Papatheofanis I, Peros G, Athanasas G, Panousopoulos D.
    Pol J Pathol; 2005 May; 56(4):179-85. PubMed ID: 16477877
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
    Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H.
    Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M, Medrano M, Mugüerza JM, Ramos P, Hernandez P, Villeta R, Martín A, Noguerales F, Ruiz A, Granell J.
    Anticancer Res; 2000 Feb; 20(5C):3907-12. PubMed ID: 11268475
    [Abstract] [Full Text] [Related]

  • 10. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
    Chang SC, Lin JK, Lin TC, Liang WY.
    Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
    [Abstract] [Full Text] [Related]

  • 11. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V, Migliavacca M, Zanna I, Tubiolo C, Corsale S, Calò V, Amato A, Cammareri P, Latteri F, Grassi N, Fulfaro F, Porcasi R, Morello V, Nuara RB, Dardanoni G, Salerno S, Valerio MR, Dusonchet L, Gerbino A, Gebbia N, Tomasino RM, Russo A.
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
    Kressner U, Lindmark G, Gerdin B, Påhlman L, Glimelius B.
    Anticancer Res; 1996 Dec; 16(2):951-7. PubMed ID: 8687158
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.
    Anticancer Res; 2001 Dec; 21(1A):253-9. PubMed ID: 11299743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis.
    Leahy DT, Salman R, Mulcahy H, Sheahan K, O'Donoghue DP, Parfrey NA.
    J Pathol; 1996 Dec; 180(4):364-70. PubMed ID: 9014855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.